← Leaderboards
Hugo Sanabria
Clemson University
$1,431,782
Attributed
$1,431,782
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $615.7K · FY2018–23$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,431,782 · 3
By mechanism
R15$879,804 · 2
P20$551,978 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Structure”
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$68,763,143
- Leonard Freedman · Leidos Biomedical Research, Inc.$67,827,589
- John Damon Chodera · Sloan-Kettering Inst Can Research$62,074,236
Research focus
StructureInsightSingle MoleculePropertyEnvironmentPositioning AttributeCellsNovel TherapeuticsLeadGenesAffinityMutationMolecularBaseDesignExperimental StudyBindingAffectFluorescence Resonance Energy TransferFoundationsComplexBiological ModelsFluorescenceMovement
Grant awards (5)
Impact of pathogenic missense mutations on the ARID domain of ARID1a$443,128
R15 · FY2023 · CA · contact PI
Modulation and inhibition of the osteoclast-specific V-ATPase for bone resorption$178,933
P20 · FY2020 · GM · contact PI
Targeting flagellar motility in the treatment of kinetoplastid diseases$436,676
R15 · FY2019 · AI · contact PI
Modulation and inhibition of the osteoclast-specific V-ATPase for bone resorption$179,046
P20 · FY2019 · GM · contact PI
Modulation and inhibition of the osteoclast-specific V-ATPase for bone resorption$193,999
P20 · FY2018 · GM · contact PI